VRG Technologies, Inc.

 

 Home Up Products Patents Investing Press Releases Contacts

  Anti-infective
 
Home
Up
 
 

 

Vector Research - Global Technologies.

 U.S. Markets for Medical Anti-Infective Agents

INTRODUCTION.

STUDY GOAL AND OBJECTIVES.

This study provides a comprehensive analysis of available and emerging anti-infective products. Its aim is to provide a range of information from detailed product analyses through industry trends to quantify and qualify the market for anti-infective products. Forecasts of product categories and industry trends are provided for the U.S. prescription and over-the-counter (OTC) markets and, when available, for international markets. Forecasts and trends are gleaned from interviews with industry sources as well as from considered assessment of available and emerging technologies.

REASONS FOR DOING THE STUDY.

The anti-infective market is facing the greatest technological challenge in its history a growing resistance by infective microorganisms to almost all available products. Researchers are comparing the emerging age of resistance to the pre-antibiotic era that existed before the discovery of penicillin. The crisis in anti-infective resistance and the strategies for combating it provide the primary reason for studying this market and what it will become.

The market for anti-infectives witnessed declining annual revenue growth during the first half of the 1990s, and is projected to grow less than 1% annually throughout the forecast period. This minimal growth is due to two factors few projected new drug launches and a substantial number of branded anti-infective agents losing patent protection and experiencing competition from lower-priced generic products.

CONTRIBUTIONS OF THE STUDY AND FOR WHOM.

This report provides a thorough background in the anti-infectives market, offering information needed to understand the current market and to approach the emerging one. It is an invaluable tool for business planners, acquisitions specialists, licensing strategists, product managers, market research analysts, investor consultants, and anyone interested in the anti-infectives market, its products, its industry participants, and its future.

SCOPE AND FORMAT.

This report on the anti-infectives market includes prescription human-use antibacterial, anthelmintic, antifungal, antiprotozoal, and antiviral agents. Vaccines are not discussed in this report. The base year for the study is 1996. Figures are based on revenue figures at the manufacturers' level and are projected at 1996 dollar value; that is, inflation is not computed into the projection figures.

Trends were assessed based on projected sales for new product introductions, increased ratios of generic products and subsequent declining prices in some categories, projected increases in the prevalence of certain diseases, and increasing prevalence of resistance to certain drugs or categories of drugs, among other factors.

Included in this report are forecasts by product segment from 1996 through 2002, including supporting analyses for all projections.

The study is arranged to offer an overview of the anti-infectives market accompanied by analyses and forecasts by product type and application. International markets are discussed, as well as information on industry structure and the regulatory environment. Profiles of manufacturers of leading anti-infectives and strategic analyses of emerging companies, as well as products in development, provide information on placement of current leading participants within the market.

METHODOLOGY.

Information to prepare this study was derived from interviews with product managers, marketing strategists, research executives, and others at leading companies in the anti-infectives industry. Interviews were also conducted with researchers and product planners at companies that do not yet participate in this market but which have products in development that are poised to be introduced during the forecast period. Discussions were also held with government agencies and regulatory bodies that monitor and/or regulate infectious diseases and their treatment. Prospectus assessments and searches of secondary material such as company annual reports and 10Ks, journal articles, government resources, and data from health care institutions were also conducted.

INFORMATION SOURCES.

Information to prepare this report was obtained from primary interviews with companies; industry analysts; health care personnel; the National Institute on Allergies and Infectious Diseases, the Centers for Disease Control and Prevention, and other government agencies; literature searches; annual reports; 10Ks; and product literature.

B-112 U.S. Markets for Medical Anti-Infective Agents 
Published June 1997 
RELATED BCC WORK CREDENTIALS INCLUDING WORK DONE BY OTHER AUTHORS

Report B-104 Rx-to-OTC Switches

Report B-108 Bulk Pharmaceutical Actives

Report C-058R Generic Prescription Drugs

Report C-092 Medical Anti-Infective Agents

Report C-170 Emerging Markets for AIDS Vaccines and Drugs

Data and analysis provided courtesy of BUSINESS COMMUNICATIONS COMPANY, INC., 25 Van Zant Street, Norwalk, CT 06855,  Telephone: (203) 853-4266; ext. 309,  Email: publisher@bccresearch.com
 

Back Home Up Next 

     

VRG Technologies, Inc.

Last Modified : 12/10/01 07:09 PM

Copyright 2001